Home › NDC Lookup › RxCUI directory › RxCUI 485496

Aripiprazole 1 MG/ML Oral Solution — RxCUI 485496

RxNorm drug concept · Semantic clinical drug
RxCUI 485496 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI485496
Official nameAripiprazole 1 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asaripiprazole 1 MG per 1 ML Oral Solution; ARIPiprazole 1 MG in 1 mL Oral Solution
FDA products mapped10
Package NDCs mapped11
Reported Medicaid activity (SDUD)51,581 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Aripiprazole: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats schizophrenia, bipolar I disorder, add-on treatment of major depressive disorder, irritability with autistic disorder, and Tourette's disorder. Which of these a product i...
  • Oral forms are taken by mouth once a day, with or without food. The long-acting injections are given by a healthcare professional. Follow your prescriber's directions.
  • Common ones include nausea, headache, dizziness, restlessness, trouble sleeping and sleepiness. Tell your doctor if they bother you.
  • Call right away for fever with stiff muscles or confusion, uncontrolled movements, fainting, seizures, new gambling urges, or worsening mood or suicidal thoughts.
📖 Read our full Aripiprazole guide →

🕸️ Concept Web — How Aripiprazole 1 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Aripiprazole 1 MG/ML Oral Solution RxCUI 485496

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Aripiprazole 89013
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Aripiprazole Oral Solution 485495
    • Aripiprazole Oral Liquid Product 1158260
    • Aripiprazole Oral Product 1158261
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • Oral Product 1151131
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Aripiprazole 1 MG/ML 485494

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Aripiprazole 1 MG/ML SCDC · 485494
  • Aripiprazole Oral Solution SCDF · 485495
  • Aripiprazole Oral Liquid Product SCDG · 1158260
  • Aripiprazole Oral Product SCDG · 1158261

📦 FDA Products & Package NDCs

10 products · 11 package NDCs
11 package NDCs map to RxCUI 485496 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
31722-0684-15 1 BOTTLE in 1 CARTON (31722-684-15) / 150 mL in 1 BOTTLE Aripiprazole Camber Pharmaceuticals, Inc. 2023-11-01
54838-0570-59 150 mL in 1 BOTTLE, PLASTIC (54838-570-59) Aripiprazole Lannett Company, Inc. 2015-08-17
54838-0570-70 237 mL in 1 BOTTLE, PLASTIC (54838-570-70) Aripiprazole Lannett Company, Inc. 2015-08-17
59651-0110-55 1 BOTTLE in 1 CARTON (59651-110-55) / 150 mL in 1 BOTTLE Aripiprazole Aurobindo Pharma Limited 2019-01-29
60505-0404-05 1 BOTTLE in 1 CARTON (60505-0404-5) / 150 mL in 1 BOTTLE aripiprazole Apotex Corp. 2015-10-08
62135-0904-51 150 mL in 1 BOTTLE (62135-904-51) Aripiprazole Chartwell RX, LLC 2025-04-28
65162-0893-74 1 BOTTLE in 1 CARTON (65162-893-74) / 150 mL in 1 BOTTLE Aripiprazole Amneal Pharmaceuticals LLC 2015-08-17
66689-0735-05 1 BOTTLE in 1 CARTON (66689-735-05) / 150 mL in 1 BOTTLE Aripiprazole VistaPharm, LLC 2020-06-19
70752-0114-07 1 BOTTLE in 1 CARTON (70752-114-07) / 150 mL in 1 BOTTLE ARIPIPRAZOLE QUAGEN PHARMACEUTICALS LLC 2025-12-15
72603-0445-01 1 BOTTLE in 1 CARTON (72603-445-01) / 150 mL in 1 BOTTLE Aripiprazole NorthStar RxLLC 2024-05-01
72888-0100-20 1 BOTTLE in 1 CARTON (72888-100-20) / 150 mL in 1 BOTTLE Aripiprazole Advagen Pharma Ltd 2022-10-27
Observed labelers: Lannett Company, Inc. (2) · Advagen Pharma Ltd (1) · Amneal Pharmaceuticals LLC (1) · Apotex Corp. (1) · Aurobindo Pharma Limited (1) · Camber Pharmaceuticals, Inc. (1) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$0.3360
Range $0.3360–$0.3360 · middle 50% $0.3360–$0.3360 · 7 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.